Resolution of Left Bundle Branch Block Due To Treatment of COVID-19-Related Myocarditis
Mustafa Yıldız1, Banu Şahin Yıldız2, Ergün Parmaksız2, Serap Yadigar2
1University of Istanbul, Institute of Cardiology, Department of Cardiology, Istanbul, Turkey
2Istanbul Kartal Dr. Lutfi Kirdar Training and Research Hospital, Department of Cardiology, Istanbul, Turkey
Keywords: Left bundle branch block, COVID-19, myocarditis
We present the case of a 67-year-old woman with novel coronavirus-infected pneumonia, who was subsequently diagnosed with coronavirus disease 2019 (COVID-19)-related myocarditis and left bundle branch block (LBBB). COVID-19-infected pneumonia treatment, such as oseltamivir, azithromycin, ceftriaxone, and ascorbic acid, may be related to the reduction of myocarditis lesion. Reduction in lesions’ size may improve the conduction system; therefore, LBBB can also be resolved in the treatment of COVID-19-infected pneumonia.
Written informed consent was obtained from the patient who participated in this study.
Concept/Design - MY; Analysis/Interpretation - BY, EP, SY; Writing - MY; Critical Revision - MY, BY; Final Approval - MY.
The authors have no conflict of interest to declare.
The authors declared that this study has received no financial support.